Hofseth BioCare ASA
OSE:HBC.OL
2.7 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 190.815 | 120.448 | 87.616 | 69.252 | 67.778 | 60.74 | 118.476 | 20.204 | 55.137 | 19.769 | 62.936 | 26.015 | 1.183 | 0.171 |
| Cost of Revenue
| 245.374 | 91.934 | 64.517 | 39.531 | 59.571 | 48.361 | 54.928 | 101.409 | 65.373 | 14.62 | 25.314 | 23.962 | 0.462 | 0 |
| Gross Profit
| -54.559 | 28.514 | 23.099 | 29.721 | 8.207 | 12.379 | 63.548 | -81.205 | -10.236 | 5.149 | 37.622 | 2.053 | 0.721 | 0.171 |
| Gross Profit Ratio
| -0.286 | 0.237 | 0.264 | 0.429 | 0.121 | 0.204 | 0.536 | -4.019 | -0.186 | 0.26 | 0.598 | 0.079 | 0.609 | 1 |
| Reseach & Development Expenses
| 11.012 | 13.635 | 12.533 | 7.563 | 0.131 | 2.43 | 1.296 | 1.789 | 4.375 | 2.824 | 1.694 | 0 | 0 | 0 |
| General & Administrative Expenses
| 21.993 | 17.871 | 31.815 | 18.673 | 8.02 | 5.539 | 5.643 | 7.331 | 9.643 | 10.189 | 12.573 | 11.597 | 0 | 0 |
| Selling & Marketing Expenses
| 13.486 | 15.042 | 13.031 | 7.863 | 4.295 | 2.225 | 0.754 | 1.807 | 2.742 | 1.343 | 0.957 | 1.367 | 0 | 0 |
| SG&A
| 65.482 | 32.913 | 44.846 | 26.536 | 12.315 | 7.764 | 6.397 | 9.138 | 12.385 | 11.532 | 13.53 | 12.964 | 0 | 0 |
| Other Expenses
| -6.124 | 1.558 | 0 | -0.086 | -8.931 | 0 | -0.777 | -0.892 | -1.222 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 71.606 | 157.131 | 141.663 | 121.827 | 88.559 | 90.855 | 75.522 | 64.25 | 84.33 | 69.56 | 86.568 | 60.097 | 25.04 | 13.076 |
| Operating Income
| -126.165 | -128.618 | -118.565 | -92.021 | -79.574 | -77.699 | -11.196 | -144.563 | -93.345 | -63.217 | -47.488 | -58.044 | -24.319 | -12.905 |
| Operating Income Ratio
| -0.661 | -1.068 | -1.353 | -1.329 | -1.174 | -1.279 | -0.095 | -7.155 | -1.693 | -3.198 | -0.755 | -2.231 | -20.557 | -75.468 |
| Total Other Income Expenses Net
| -6.696 | -8.772 | -7.899 | -10.07 | -9.644 | -6.828 | -5.286 | -2.896 | -6.857 | -3.723 | -4.679 | -4.951 | -1.395 | -0.134 |
| Income Before Tax
| -109.225 | -137.39 | -126.464 | -102.091 | -89.218 | -84.527 | -16.482 | -147.459 | -100.202 | -66.94 | -52.167 | -62.995 | -25.714 | -13.039 |
| Income Before Tax Ratio
| -0.572 | -1.141 | -1.443 | -1.474 | -1.316 | -1.392 | -0.139 | -7.299 | -1.817 | -3.386 | -0.829 | -2.421 | -21.736 | -76.251 |
| Income Tax Expense
| -2.543 | 1.181 | 1.494 | -1.008 | -1.278 | 0.249 | -1.97 | 3.251 | 2.523 | 7.14 | -0.631 | 11.529 | -6.68 | -3.653 |
| Net Income
| -106.682 | -137.389 | -126.463 | -102.09 | -89.209 | -84.768 | -16.475 | -147.45 | -100.194 | -66.918 | -52.136 | -73.86 | -19.036 | -9.387 |
| Net Income Ratio
| -0.559 | -1.141 | -1.443 | -1.474 | -1.316 | -1.396 | -0.139 | -7.298 | -1.817 | -3.385 | -0.828 | -2.839 | -16.091 | -54.895 |
| EPS
| -0.27 | -0.37 | -0.35 | -0.31 | -0.29 | -0.33 | -0.07 | -1.01 | -0.95 | -0.73 | -0.72 | -1.29 | -0.45 | -0.33 |
| EPS Diluted
| -0.27 | -0.37 | -0.35 | -0.31 | -0.29 | -0.33 | -0.07 | -1.01 | -0.94 | -0.72 | -0.7 | -1.25 | -0.43 | -0.33 |
| EBITDA
| -70.602 | -97.008 | -85.568 | -68.282 | -55.49 | -58.508 | 8.536 | -118.539 | -74.28 | -44.597 | -33.977 | -50.022 | -22.622 | -12.829 |
| EBITDA Ratio
| -0.47 | -0.806 | -1.001 | -0.957 | -0.788 | -0.941 | 0.072 | -5.702 | -1.31 | -2.125 | -0.564 | -1.923 | -18.254 | -75.023 |